Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000097:blood / Q000627:therapeutic use*; D001769:Blood; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011183:Postoperative Complications; D011247:Pregnancy; D011720:Pyrazoles / Q000097:blood / Q000627:therapeutic use*; D013729:Terpenes / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014470:Umbilical Cord
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013729:Terpenes